Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
---|---|---|---|---|---|---|---|---|
EWTX | EDGEWISE THERAPEUTICS INC | 5.03% | 15,518,492 | $203,447,430 | 496,771 | 3.31% | $13.11 | 13F |
EW | EDWARDS LIFESCIENCES CORP | 3.30% | 1,708,000 | $133,582,680 | 176,000 | 11.49% | $78.21 | 13F |
ARGX | ARGENX SE | 2.83% | 208,000 | $114,653,760 | 1,300 | 0.63% | $551.22 | 13F |
UNH | UNITEDHEALTH GROUP INC | 2.59% | 336,300 | $104,915,511 | 135,100 | 67.15% | $311.97 | 13F |
NTRA | NATERA INC | 2.48% | 593,434 | $100,254,740 | 46,434 | 8.49% | $168.94 | 13F |
VRTX | VERTEX PHARMACEUTICALS INC | 2.31% | 210,287 | $93,619,772 | 50,387 | 31.51% | $445.2 | 13F |
AXSM | AXSOME THERAPEUTICS INC | 1.10% | 427,900 | $44,668,481 | 41,200 | 10.65% | $104.39 | 13F |
CRNX | CRINETICS PHARMACEUTICALS IN | 0.82% | 1,149,000 | $33,045,240 | 150,000 | 15.02% | $28.76 | 13F |
CRVS | CORVUS PHARMACEUTICALS INC | 0.71% | 7,165,006 | $28,660,024 | 221,352 | 3.19% | $4 | 13F |
JANX | JANUX THERAPEUTICS INC | 0.69% | 1,210,300 | $27,957,930 | 451,734 | 59.55% | $23.1 | 13F |
APLS | APELLIS PHARMACEUTICALS INC | 0.63% | 1,482,300 | $25,658,613 | 50,000 | 3.49% | $17.31 | 13F |
GPCR | STRUCTURE THERAPEUTICS INC | 0.62% | 1,199,300 | $24,873,482 | 547,272 | 83.93% | $20.74 | 13F |
AGIO | AGIOS PHARMACEUTICALS INC | 0.46% | 557,900 | $18,555,754 | 232,400 | 71.4% | $33.26 | 13F |
TRVI | TREVI THERAPEUTICS INC | 0.45% | 3,308,400 | $18,096,948 | 2,188,400 | 195.39% | $5.47 | 13F |
FBRX | FORTE BIOSCIENCES INC | 0.38% | 1,196,955 | $15,476,628 | 603,867 | 101.82% | $12.93 | 13F |
VIR | VIR BIOTECHNOLOGY INC | 0.30% | 2,380,715 | $11,998,804 | 132,466 | 5.89% | $5.04 | 13F |
AKRO | AKERO THERAPEUTICS INC | 0.28% | 211,300 | $11,274,968 | 31,400 | 17.45% | $53.36 | 13F |
DYN | DYNE THERAPEUTICS INC | 0.24% | 1,031,400 | $9,818,928 | 16,789 | 1.65% | $9.52 | 13F |
ORIC | ORIC PHARMACEUTICALS INC | 0.23% | 899,281 | $9,127,702 | 199,281 | 28.47% | $10.15 | 13F |